The relative benefits and limitations of many traditional methods for measuring glycated haemoglobin (GHb) have been well described.' Many of these methods measure total HhA, (HbA l a + HbA l b + HbA 1c ) and not HbA l c specifically. For clinical purposes this should be satisfactory because changes in HhA, parallel those in HbA l c ' However, Hb.A. concentrations are more subject to artefactual change during sample storage and to interference from nonglucose adducts of haemoglobin, and measurement of HbA l c may thus be advantageous. 2 Methods which fail to take account of the presence of variant haemoglobins or of labile aldimine intermediate (pre-HhAj.) may introduce large errors in the measurement of GHb.
We report evaluation results for a new assay for the specific measurement of HbA l c (Diatrac, Beckman Instruments UK Ltd, High Wycombe, UK). The method relies upon separation of HbA lc by gel electrophoresis at acid pH, followed by densitometry of unstained fractions to quantitate the proportion of HbA lc present. The use of a low pH and the inclusion of certain (unspecified) agents in the electrophoresis medium are likely to account for separation of HbA l c from HbA la + b; other commercially available electrophoresis methods quantitate total HbA l • The Diatrac procedure also separates HbA lc from a number of variant haemoglobins, and the presence of these should not, therefore, interfere with the measurement. Furthermore, the technique for preparing haemolysates during the Diatrac procedure is claimed to remove pre-HhAj, without prolonged treatment of erythrocytes.
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METHOD
All reagents and equipment were provided by the manufacturer and used according to their recommendations. Gels were first equilibrated with 0·2 M tris-maleic acid buffer, pH 5·4.
Blood (20 ILL) was thoroughly mixed with 50 ILL of haemolysing solution and O' 5 ILL of haemolysate applied, via a disposable template, to one of 10 positions on an agarose gel. Following a 10 min penetration of haemolysate into the gel, electrophoresis was performed at 50 volts for 35 min with 1 M tris-maleic acid buffer. Gels were then washed in water for I min and, without drying, the separated fractions were scanned at 415 nm using a Beckman Appraise densitometer. After editing the densitometer scans, peak areas were automatically determined by integration.
RESULTS AND DISCUSSION
Within-assay imprecision of the method was assessed from replicate measurements of patient samples at two concentrations (sample 1: n = 10, mean 9'4070, SD 0'22, CV 2·3%; sample 2: n = 9, mean 6'1%, SDO'14, CV2·3%). Betweenassay imprecision was assessed from replicate measurements of control samples at two concentrations (sample 1: n = 28, mean 4· 9%, SDO'24, CV4'9%; sample 2: n=28, mean 9'2%, SDO'30, CV3·8%).
Results obtained for patient samples by the Diatrac HbA l c assay were compared with HhA, values obtained by the Biorad mini-column ion-exchange chromatography (MIEC) method [Bio-Rad Laboratories Ltd, Watford, UK (n = 102, Diatrac=0'86xMIEC+0'0, r=0'93] and, for a separate series of samples, with HbA l c values obtained using the Biorad MDMS HPLC system (n=72, Diatrac e O-Sl xHPLC+0'65, r=0·95). Results were also obtained for six samples The Diatrac assay represents a reliable and useful alternative to existing methods for the measurement of GHb, being particularly well suited to small and medium sized workloads. HbF, HbS and HbC. (b. c and d. respectively) . Peaks: l-HbA", 2-HbA l e • 3-HbA I a+ 11J' 4-HbF. 5-HbS. 6-HbC.
FIGURE I. Separation of HbA tc and haemoglobin variants from HbA o in a sample from a patient with diabetes (a). and in samples containing
(samples 106-111) distributed in the UK National External Quality Assurance Scheme (NEQAS). Diatrac assay values for NEQAS samples were 5'9-15,5070 (mean 9'9%) higher than HbA l c values reported for ion-exchange chromatography (lEC) and 10· 9-19' 5% (mean 14·5 %) lower than mean values for all methods measuring total HbA l . The reason for the Diatrac assay yielding higher values than HbA l c results reported by NEQAS for all lEC methods is uncertain, but may be due to artefactual factors affecting only these samples. For patient samples, Diatrac values agreed closely with HbA lc results obtained by ion-exchange HPLC.
Linearity of the method was investigated by measuring a set of samples produced by mixing blood specimens containing high and low concentrations of HbA l c in different proportions. The assay was linear in the range 3'3-17'4% HbA l c (r=0·999).
Removal of pre-HbAj, by sample haemolysate preparation was investigated. Blood was incubated at 37°C for 3 h with varying concentrations (0-50 mmollL) of glucose. One half of each sample portion was then incubated overnight in 0·9% saline to remove pre-HbA lc ' Haemolysates were prepared and HbA l c measured both in the sample portions incubated in saline and those which had not been subjected to this procedure. At glucose concentrations of 10 and 20 mmollL, HbA l c values obtained with and without overnight saline washing were almost identical (recoveries without washing 102% and 103%, respectively). However, at glucose concentrations of 30-50 mmollL, HbA 1c values were 10-12% higher when the overnight saline wash was omitted, suggesting possible interference from pre-HbA l c '
The effect of HbF on HbA l c quantitation was investigated by addition of varying amounts of cord blood to normal adult blood. The presence of I . 9-15 . 3% HbF had only a modest effect on HbA 1c recovery (range of recoveries 91-109%). There was no significant correlation between HbF in this concentration range and HbA 1c recovery (P>O·lO). However, at higher concentrations of HbF, separation from HbA l c was incomplete
